BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rala de Paula BH, Costa METF, de Sousa CAM, Bines J. Is there a window of opportunity to optimize trastuzumab cardiac monitoring? World J Cardiol 2022; 14(7): 403-410 [PMID: 36161060 DOI: 10.4330/wjc.v14.i7.403]
URL: https://www.wjgnet.com/1949-8462/full/v14/i7/403.htm
Number Citing Articles
1
Anthracyclines/trastuzumabReactions Weekly 2022; 1931(1): 46 doi: 10.1007/s40278-022-26843-x
2
Alaa Shahbar, Abdullah A Alhifany, Yasser M Alatawi, Mohammed Alnuhait, Abdullah Alshammari, Majed Alshamrani, Abdulhalim Kinsara, Atif AlQubbany, Mahasen Alharbi, Abdelmajid Alnatsheh, Meteb Alfoheidi. Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi ArabiaClinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241297881